Greensboro Practice Recognized for MS Care
National Multiple Sclerosis Society cites Guilford Neurological Associates for care of people with MS.
The MS Center of Guilford Neurologic Associates has been acknowledged for its expertise in treating people with Multiple Sclerosis (MS). The recognition comes through the National Multiple Sclerosis Society’s Partners in MS Care program. Guilford Neurologic Associates is a member of Cone Health Medical Group.
This recognition honors Guilford Neurologic Associates’ commitment to providing exceptional, coordinated MS care.
Dr. Richard Sater accepts award
“We take a team approach to treating MS,” says Richard Sater, MD, PhD, medical director, MS Center. “Everyone from neurologists to occupational and physical therapists bring exceptional and complete care to our patients.” The practice also collaborates with the Society to address the challenges of people affected by MS.
The Society’s Partners in MS Care program recognizes practices that support the Society’s initiative of affordable access to high-quality MS health care for everyone living with MS – regardless of geography, disease progression and other disparities.
“We are so proud to partner with Guilford Neurologic Associates to enhance coordinated, comprehensive care for the people who live with MS in the Greater Greensboro area and indeed in the greater Piedmont Triad,” said Kristina Fransel of the National MS Society, Greater Carolinas. “In earning this recognition, Guilford Neurologic Associates has demonstrated extraordinary leadership in MS care, making a tremendous impact on people affected by MS in our community.”
Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms vary and range from numbness and tingling, to walking difficulties, fatigue, dizziness, pain, depression, blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million worldwide.